Correlation Between Clearpoint Neuro and Neuropace

Can any of the company-specific risk be diversified away by investing in both Clearpoint Neuro and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearpoint Neuro and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clearpoint Neuro and Neuropace, you can compare the effects of market volatilities on Clearpoint Neuro and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearpoint Neuro with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearpoint Neuro and Neuropace.

Diversification Opportunities for Clearpoint Neuro and Neuropace

0.68

Correlation Coefficient

Clearpoint Neuro  Neuropace

Poor diversification

The 3 months correlation between Clearpoint and Neuropace is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Clearpoint Neuro and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Clearpoint Neuro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearpoint Neuro are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Clearpoint Neuro i.e., Clearpoint Neuro and Neuropace go up and down completely randomly.

Pair Corralation between Clearpoint Neuro and Neuropace

Given the investment horizon of 90 days Clearpoint Neuro is expected to under-perform the Neuropace. In addition to that, Clearpoint Neuro is 1.28 times more volatile than Neuropace. It trades about -0.06 of its total potential returns per unit of risk. Neuropace is currently generating about 0.04 per unit of volatility. If you would invest  1,119  in Neuropace on December 31, 2024 and sell it today you would earn a total of  66.00  from holding Neuropace or generate 5.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Clearpoint Neuro  vs.  Neuropace

Clearpoint Neuro

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clearpoint Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace may actually be approaching a critical reversion point that can send shares even higher in May 2025.

Pair Trading with Clearpoint Neuro and Neuropace

The main advantage of trading using opposite Clearpoint Neuro and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearpoint Neuro position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Clearpoint Neuro and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.